Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.22 USD | -5.43% | -8.27% | -35.11% |
May. 15 | HC Wainwright Adjusts IO Biotech Price Target to $12 From $8, Maintains Buy Rating | MT |
May. 14 | IO Biotech, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-35.11% | 84.99M | |
+46.82% | 58.71B | |
-3.50% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.44% | 26.55B | |
-22.61% | 18.98B | |
+1.57% | 12.51B | |
+24.82% | 12.08B | |
+21.80% | 11.94B |
- Stock Market
- Equities
- IOBT Stock
- News IO Biotech, Inc.
- IO Biotech Says Non-Small Cell Lung Cancer Therapy Showed Partial Response in More Than Half of Evaluable Patients